EDMP Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,174
| Closed | -$314K | – | 75 |
|
|
2026
Q1 | $314K | Sell |
11,174
-776
| -6% | -$20.7K | 0.25% | 61 |
|
|
2025
Q4 | $298K | Hold |
11,950
| – | – | 0.24% | 60 |
|
|
2025
Q3 | $304K | Hold |
11,950
| – | – | 0.24% | 60 |
|
|
2025
Q2 | $290K | Sell |
11,950
-1,389
| -10% | -$32.4K | 0.25% | 59 |
|
|
2025
Q1 | $338K | Sell |
13,339
-193
| -1% | -$5.05K | 0.28% | 60 |
|
|
2024
Q4 | $359K | Buy |
13,532
+2,252
| +20% | +$61.1K | 0.34% | 51 |
|
|
2024
Q3 | $326K | Buy |
+11,280
| New | +$329K | 0.27% | 63 |
|
|
2023
Q4 | – | Sell |
-60,556
| Closed | -$2.01M | – | 73 |
|
|
2023
Q3 | $2.01M | Sell |
60,556
-3,015
| -5% | -$107K | 2.05% | 19 |
|
|
2023
Q2 | $2.33M | Buy |
63,571
+492
| +0.8% | +$19.1K | 2.22% | 18 |
|
|
2023
Q1 | $2.57M | Sell |
63,079
-1,555
| -2% | -$67.2K | 2.58% | 15 |
|
|
2022
Q4 | $3.31M | Sell |
64,634
-1,408
| -2% | -$67.5K | 3.26% | 12 |
|
|
2022
Q3 | $2.89M | Sell |
66,042
-164
| -0.2% | -$7.97K | 3.08% | 13 |
|
|
2022
Q2 | $3.47M | Sell |
66,206
-531
| -0.8% | -$27.1K | 3.39% | 10 |
|
|
2022
Q1 | $3.46M | Sell |
66,737
-1,180
| -2% | -$61.2K | 3.25% | 8 |
|
|
2021
Q4 | $4.01M | Sell |
67,917
-3,055
| -4% | -$151K | 3.99% | 7 |
|
|
2021
Q3 | $3.05M | Sell |
70,972
-97
| -0.1% | -$4.3K | 3.23% | 10 |
|
|
2021
Q2 | $2.78M | Sell |
71,069
-272
| -0.4% | -$10.6K | 2.92% | 11 |
|
|
2021
Q1 | $2.58M | Sell |
71,341
-3,245
| -4% | -$115K | 2.74% | 12 |
|
|
2020
Q4 | $2.75M | Sell |
74,586
-5,477
| -7% | -$201K | 3.75% | 7 |
|
|
2020
Q3 | $2.79M | Sell |
80,063
-1,993
| -2% | -$69.9K | 4.1% | 7 |
|
|
2020
Q2 | $2.55M | Sell |
82,056
-3,246
| -4% | -$110K | 3.96% | 7 |
|
|
2020
Q1 | $2.64M | Sell |
85,302
-2,391
| -3% | -$81.5K | 2.34% | 18 |
|
|
2019
Q4 | $3.26M | Sell |
87,693
-1,027
| -1% | -$36.6K | 2.78% | 14 |
|
|
2019
Q3 | $3.07M | Sell |
88,720
-2,670
| -3% | -$97.1K | 2.73% | 13 |
|
|
2019
Q2 | $3.76M | Sell |
91,390
-6,108
| -6% | -$243K | 3.44% | 10 |
|
|
2019
Q1 | $3.93M | Sell |
97,498
-1,507
| -2% | -$60.4K | 3.83% | 8 |
|
|
2018
Q4 | $4.1M | Sell |
99,005
-1,998
| -2% | -$82.9K | 4.6% | 5 |
|
|
2018
Q3 | $4.22M | Sell |
101,003
-521
| -0.5% | -$20.1K | 3.98% | 5 |
|
|
2018
Q2 | $3.5M | Sell |
101,524
-2,045
| -2% | -$69.9K | 3.6% | 9 |
|
|
2018
Q1 | $3.49M | Sell |
103,569
-1,270
| -1% | -$43.7K | 3.45% | 9 |
|
|
2017
Q4 | $3.63M | Sell |
104,839
-4,933
| -4% | -$168K | 3.1% | 12 |
|
|
2017
Q3 | $3.72M | Sell |
109,772
-922
| -0.8% | -$29.6K | 3.35% | 9 |
|
|
2017
Q2 | $3.53M | Buy |
110,694
+611
| +0.6% | +$19.3K | 3.26% | 10 |
|
|
2017
Q1 | $3.57M | Buy |
+110,083
| New | +$3.47M | 3.21% | 10 |
|
Other funds holding PFE
EDMP Inc's PFE Position: Q2 2026 in Review
EDMP Inc sold out of Pfizer (PFE) in Q2 2026, closing a stake of 11,174 shares — an estimated $314K sold.
EDMP Inc first reported a position in PFE in Q1 2017 and held it in 34 quarters. The position peaked at $4.22M in Q3 2018. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- EDMP Inc reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- EDMP Inc sold 11,174 Pfizer shares in Q2 2026, an estimated $314K.
- EDMP Inc first reported a position in Pfizer in Q1 2017 and held it in 34 quarters.
- EDMP Inc's Pfizer position peaked at $4.22M in Q3 2018.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on EDMP Inc's 13F filing for Q2 2026, filed 29 Jul 2026.